Generic Lenacapavir Approval Could Widen Access to Twice-Yearly HIV Prevention
FDA tentative approval of a generic version of lenacapavir could bring the twice-yearly HIV prevention shot to 120 low-income countries at about $40 a year.
Nov 3, 2026 · 4 min read
188 views · ◆ 0 CYBEV